Clinical trial Recruiting at 1 site Interventional Ages 18 and up

ExoBDNF probiotic to help thinking, sleep, and mood

Official title: Effect of ExoBDNF Lactic Acid Bacteria Supplement on Cognitive Functions, Sleep and Psychological Outcomes: An Open-label Trial

Run by SunWay Biotech Co., LTD. · NCT06968299 · Data updated 2026-11-12

This study will test whether taking one daily capsule of ExoBDNF probiotic for 8 weeks can help adults 18+ improve cognition, sleep quality, or mood symptoms.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorSunWay Biotech Co., LTD.
Industry-sponsored
Locations1 site (Taipei)
StatusRecruiting
StartedMay 20, 2025
Main results expectedDecember 30, 2025
Study endsDecember 30, 2025
Registry record updatedNovember 24, 2025
Trial IDNCT06968299 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are mentally clear adults aged 18 or older who can attend in-person visits and who are seeking to improve mild cognitive, sleep, or psychological complaints and can comply with daily supplement use.

Probably not a fit

People with major medical conditions (severe heart, liver, kidney disease), recent brain surgery or severe brain injury, certain gastrointestinal diseases, pregnancy, or very high blood pressure are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This open-label, single-group pre/post-test study will enroll about 30 adults who will take a capsule containing 1 x 10^10 CFU of Pediococcus acidilactici ExoBDNF once daily for 8 weeks. Cognitive function, subjective cognitive complaints, sleep quality, and symptoms of depression/anxiety/stress will be measured at baseline and after treatment using standardized scales (MMSE, MoCA, PSQI, DASS-21, and others). Blood tests and fecal microbiome analyses will be performed before and after supplementation, and participants will keep a daily diary of product intake, diet, bowel habits, and any symptoms. The protocol requires participants to maintain a regular lifestyle during the intervention to limit other influences on outcomes.

Why it matters

Potential benefit: If successful, ExoBDNF probiotic supplementation could modestly improve cognitive performance, sleep quality, and mood in some adults.

How similar studies have gone: Some prior probiotic studies have shown small benefits for mood and cognitive markers, but using Pediococcus acidilactici that delivers ExoBDNF is a relatively novel approach with limited human data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Subjects must be volunteers who are 18 years of age or older, mentally clear and able to communicate.
2. Subjects who agree to participate in this trial and voluntarily sign the trial consent form.

Exclusion Criteria:

1. Subjects who are expected to be or have been confirmed to be pregnant (medical history).
2. Subjects with gallbladder disease, gastrointestinal disease, gout, porphyria, or a history of gastric weight control surgery.
3. Subjects with high blood pressure (≥160/100 mmHg after resting for 10 minutes) or taking diuretics.
4. Subjects with heart disease, hepatorenal insufficiency, hyperthyroidism or hypothyroidism, Cushing's syndrome, malignant tumors, or any other disease that may affect the results of the study.
5. Subjects with severe hearing or visual impairment that makes it impossible to perform examinations and assessments.
6. Subjects with any history of brain surgery, penetrating, neurovascular, infectious or other severe brain injury, epilepsy or other major neurological abnormalities, such as traumatic brain injury with loss of consciousness for more than 24 hours, or memory loss after head trauma for more than 7 days were excluded.
7. Subjects with intellectual disabilities.
8. Subjects who had consumed probiotics or were expected to consume probiotics within 2 weeks before the screening visit.
9. Subjects who had participated in or were expected to participate in clinical trials within 4 weeks before the screening visit.

Where it's running

  • Tri-Service General Hospital, National Defense Medical Center
    Taipei, Taiwan
    Recruiting

Study contacts

  • Principal investigator: Hsin-An Chang, MD — Director, Child and Adolescent Psychiatry, Department of Psychiatry
  • Study coordinator: Sean Lin
  • Email: sean.lin@sunway.cc
  • Phone: 02-27929568

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.